Form 4 for BNTC Benitec Biopharma Inc.
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001062993-25-004077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-27 | BNTC | BUCHI J KEVIN | Dir | M - OptEx | $3.86 | +51.8K | 103.9K | +99% | +$200.0K |
| D | 2025-03-03 | 2025-02-27 | BNTC | BUCHI J KEVIN | Dir | M - OptEx | $0.00 | -51.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-27 | M | A | 51,813 | $3.86 | 103,910 | D | — | — | |
| 2 | Derivative | Common Warrants (right to buy) | 2025-02-27 | M | D | 51,813 | $0.00 | 0 | D | $3.86 · 2023-08-11 to 2028-08-11 | 51,813 Common Stock |